Aurinia Pharmaceuticals (AUPH) Intangibles (2016 - 2026)

Aurinia Pharmaceuticals' Intangibles history runs 11 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• Quarterly Intangibles fell 13.66% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 13.66% YoY) and the FY2025 annual result came in at $3.8 million, down 13.64% from the prior year.
• Intangibles was $3.6 million for Q1 2026 at Aurinia Pharmaceuticals, down from $3.8 million in the prior quarter.
• Across five years, Intangibles topped out at $7.9 million in Q1 2022 and bottomed at $3.6 million in Q1 2026.
• A 5-year average of $5.2 million and a median of $4.8 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles slipped 23.55% — and 2025, when it slipped 12.44%.
• Aurinia Pharmaceuticals' Intangibles stood at $6.4 million in 2022, then slipped by 22.54% to $5.0 million in 2023, then slipped by 12.5% to $4.4 million in 2024, then slipped by 13.64% to $3.8 million in 2025, then dropped by 4.55% to $3.6 million in 2026.
• Business Quant data shows AUPH's Intangibles at $3.6 million in Q1 2026, $3.8 million in Q4 2025, and $3.9 million in Q3 2025.